Bugtong, Lorena R.
HRN: 26-35-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
12/28/2024
12/28/2024
IV
500 Mg
Now
Pleural Effusion
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes